Cell Therapy Media and Accessory
Irvine Scientific® offers the PRIME-XV® Media Portfolio comprising xeno- and serum-free expansion and differentiation media for utilization in cell therapy and regenerative medicine, e.g. for:
- Dendritic Cells: PRIME-XV® Dendritic Cell Maturation CDM
- T Cells: PRIME-XV® T Cell Expansion XSFM / CDM
- MSCs: PRIME-XV® MSC Expansion XSFM
- PRIME-XV® Media for Osteogenesis, Adipogenesis and Chondrogenesis
- Neural Cells: PRIME-XV® Neural Basal Medium
- Amniotic Fluid Stem Cells: PRIME-XV® AFSC Expansion Medium
- Cancer Stem/ Initiating Cells: PRIME-XV® Tumorsphere SFM
- HPCs: PRIME-XV® Human / Mouse Hematopoietic Cell Basal Medium
The portfolio is complemented by
- Cell Cryopreservation Solutions: PRIME-XV® FreezIS / PRIME-XV® MSC FreezIS DMSO-Free
- Attachement Substates (PRIME-XV® MatrIS / PRIME-XV® Human Fibronectin)
- Recombinant Growth Factors / Cytokines
The validated media and supplements are manufactured under full cGMP conditions and fulfill CE regulations. Quality and regulatory accordance is a matter of course, as Irvine Scientific® is grounded in assisted reproductive technology (ART), cytogenetic applications and industrial cell culture.
Irvine Scientific® experts in R&D, manufacturing and regulatory affairs are gladly available to assist you with your project.
TRINOVA BIOCHEM is the distributor for the PRIME-XV® Cell Therapy Media Portfolio in Germany, Austria and Switzerland.
For over 25 years, Irvine Scientific® weltweit führend mit Zellkulturmedien für die Pränataldiagnostik und weitere zytogenetische Untersuchungen. CHANG Medium® is the considered to be the gold standard for cytogenetics application.
As exclusive Distributor for Germany TRINOVA BIOCHEM offers a range of media for culturing amniotic fluid cells, chorionic villi sampling or tissues using either flask or in situ methodology. In postnatal cytogenetics, we offer media for the culturing of bone marrow aspirates and peripheral blood cells.